Delivery Order SPE2DB22D3501-SPE2DB24FUW52
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of VYVGART 400 mg/20 ml vials totaling $12,792.51 with an ultimate completion date of August 11, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child delivery order under AmerisourceBergen's substantial...
- The U.S. Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a firm fixed price delivery order contract worth $48,621.84 to provide VYVGART 400 MG/20 ML VIAL 20ML pharmaceutical products. This contract has a completion date of March 12, 2024. Amerisourcebergen Drug Corp, a for-profit organization, serves as the prime contractor for this award. This delivery order contract is issued under a larger indefinite delivery contract (IDC)...
- This is a $12,792.51 firm fixed-price delivery order contract awarded by the Defense Logistics Agency to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of the pharmaceutical product VYVGART 400 MG/20 ML VIAL 20ML, with an ultimate completion date of July 1, 2025. The contract is not set aside and is an open competition award. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office Division, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government. The contract, valued at $16,207.28, is for the delivery of VYVGART 400 MG/20 ML VIAL 20ML, a pharmaceutical product. The contract has a firm fixed price pricing type and a completion date of May 7, 2024. It is not designated as a set-aside contract. In addition...
- This is a Delivery Order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp's Corporate Office Division. The contract is for the supply of VYVGART 400 MG/20 ML VIAL 20ML, a specialty pharmaceutical product, with a ceiling value of $16,207.28. The contract has an ultimate completion date of October 16, 2024 and is a Firm Fixed Price Delivery Order. AmerisourceBergen is a major supplier of pharmaceutical products and medical supplies to the U.S....
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a $23,976.78 firm fixed price delivery order contract by the Defense Logistics Agency (DLA) for 400 mg/20 ml vials of the pharmaceutical product VYVGART. This delivery order has a completion date of November 17, 2023. Amerisourcebergen Drug Corp serves as a prime contractor providing pharmaceutical products and medical supplies to U.S. government agencies, including the Department of Defense. The company...
- The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract has a potential value of $8,103.66 and a completion date of March 25, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded by DLA to AmerisourceBergen Drug Corp, with a potential value of up to...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation. The order is for VYVGART 400 MG/20 ML VIAL 20ML, a pharmaceutical product. The contract has a ceiling value of $24,310.92 and a completion date of June 4, 2024. The contract is a firm fixed price delivery order and is not designated as a set-aside. AmerisourceBergen Drug Corporation is a subsidiary of Cencora, Inc., one of the largest pharmaceutical distribution...
- This is a firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of VYVGART 400 MG/20 ML VIAL 20ML, a prescription medication, with a ceiling value of $38,377.53 and a performance period through July 8, 2025. The contract is not set aside and was competitively awarded. AmerisourceBergen Drug Corp holds a significant Indefinite...
- The Defense Logistics Agency awarded a $12.8K delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Vyvgart 400 mg/20 ml vials. The contract is non-set-aside and competitively awarded with firm fixed pricing, with an ultimate completion date of September 3, 2025. AmerisourceBergen will perform the work at its corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery...
- SPE2DB22D3501Indefinite Delivery Contract
- SPE2DB22D3501-SPE2DB24FUW52Delivery Order
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of the for-profit global pharmaceutical company AmerisourceBergen Corporation. The contract, valued at $16,207.28, is for the delivery of the pharmaceutical product VYVGART 400 MG/20 ML VIAL 20ML. The order has an ultimate completion date of April 1, 2024. AmerisourceBergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the company to deliver pharmaceuticals and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. This specific delivery order is issued under that IDC, which does not have any set-aside designations. AmerisourceBergen Corporation is the parent company of the prime contractor, AmerisourceBergen Drug Corp.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $16.2k | 3/11/24 |